Efficacy of Stiripentol in Dravet Syndrome with or without SCN1A Mutations

BACKGROUND AND PURPOSE: The aim of this study was to determine the effectiveness of stiripentol (STP) add-on therapy to valproate and clobazam in patients with Dravet syndrome (DS) according to the presence of mutations in the sodium channel alpha-1 subunit gene (SCN1A). METHODS: We performed direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Min Jung, Kwon, Soon Sung, Ko, Ara, Lee, Seung-Tae, Lee, Young Mock, Kim, Heung Dong, Chung, Hee Jung, Kim, Se Hee, Lee, Joon Soo, Kim, Dae-Sung, Kang, Hoon-Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765252/
https://www.ncbi.nlm.nih.gov/pubmed/29141279
http://dx.doi.org/10.3988/jcn.2018.14.1.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765252/
https://www.ncbi.nlm.nih.gov/pubmed/29141279
http://dx.doi.org/10.3988/jcn.2018.14.1.22

Ejemplares similares